Hepalatide 2.1mg

DRUG2 trials

Sponsors

Shanghai HEP Pharmaceutical Co., Ltd.

Conditions

Hepatitis B, ChronicHepatitis D, Chronic

Phase 2

A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B

CompletedNCT04426968

Shanghai HEP Pharmaceutical Co., Ltd.Hepatitis B, Chronic

Start: 2021-06-18End: 2023-11-29Updated: 2025-01-27

Phase 3

Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Not yet recruitingNCT07309380

Shanghai HEP Pharmaceutical Co., Ltd.Hepatitis D, Chronic

Start: 2026-04-30End: 2027-08-31Target: 150Updated: 2025-12-30